Please enter subscribe form shortcode
Please enter instagram feed shortcode
MIM Pharma’s system-biology-based pharmaceutical composition comprising a mixture of medical plant extracts as active ingredients, and use of said composition as a medicament, particularly in the treatment of human coronavirus infections such as COVID-19 has been published under the patent cooperation treaty (PCT). International Publication Number WO 2022/250542
Efficacy of a multiple-indication antiviral herbal drug for COVID-19 outpatients: A pre-clinical and randomized clinical trial study The scientific researches on COVID-19 pandemic topics are headed to an explosion of scientific literature. Despite these global efforts, the efficient treatment of patients is an in-progress challenge. Based on a meta-study of published shreds of evidence about […]
Based on our extensive research and development, the R&D team of MIM PHARMA successfully developed a novel natural anti-viral drug. The proper shapes of the drug match the stages of Covid-19 and its clinical considerations. The drug performs as a very strong Covid-19 inhibitor with remarkable curative effects! Base on our clinical trials, symptoms, and […]
